• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

New York Lays the Groundwork for Legalizing Cannabis

The potential of legal New York adult-use cannabis sales have been estimated at $1.5 billion a year by 2023.
By DEBRA BORCHARDT
Oct 29, 2020 | 09:00 AM EDT
Stocks quotes in this article: CGC, CCHWF, CURLF, MMNFF, ACRHF, VREOF

Several key people in key positions in the State of New York have signaled an increasing openness to the idea of legalizing adult use cannabis. The item has appeared on the state budget but for various reasons but never got beyond that status. Now as the pandemic has wrecked the state's economy, it's looking more and more like a reality.

"It was being considered even prior to the pandemic but now more than ever, as we're finding how cash strapped our state will be as we run out of revenues, I think it will absolutely be on the table for consideration in the next budget," Lieutenant Governor Kathy Hochul recently said. Governor Cuomo weighed in saying that the state will legalize marijuana "soon" to help with the economic recovery from the coronavirus pandemic. He was quoted as saying that "We need revenue and we're going to be searching the cupboards for revenue. And I think that is going to put marijuana over the top."

Canopy Growth (CGC) has a new video series hosted by David Culver called, "Under The Canopy," and Cuomo's Assistant Counsel Axel Bernabe appears on the show. He spoke about how bordering states that have legalized adult use cannabis are pushing for New York to consider making changes. According to Bernabe, the governor will be introducing legislation that will serve as a "model" for other states, prioritizing social equity and economic development.

"We're watching New Jersey closely. We've always been confident that we get to this before New Jersey, so if they pass the referendum they still have to have agreement between the governor and the Senate over there," he said, referring to necessary implementing legislation that will need to be approved if voters pass the ballot question. "We're working on this. We're going to reintroduce this in our budget in January. We think we can get it done by April 1."

Elliot Choi, counsel at Vicente Sederberg LLP's New York office said, "The size of the New York market cannot be overstated. The population of New York City alone is greater than that of Massachusetts and Rhode Island combined. New York already appears to be headed toward legalization, but passage of Public Question 1 in New Jersey would provide additional motivation for the Legislature to get it done in the upcoming session. There will likely be some form of coordination between the two states, or multiple states in the region, as Gov. Cuomo and other Northeast governors have previously indicated their intention to work together. This coordination could result in, among other things, New Jersey and New York imposing similar tax rates and/or launching their markets around the same time in order to deter customers from crossing state lines to make purchases." 

New York has only issued 10 medical marijuana licenses and each of those holders can only open four locations. The publicly traded companies include Columbia Care (CCHWF) , Curaleaf (CURLF) , MedMen (MMNFF) , Acreage Holdings (ACRHF) and Vireo Health (VREOF) . The private companies include Citiva Medical, Etain, Fiorello Pharmaceuticals PharmaCann, and Valley Agriceuticals. At one point MedMen was planning on acquiring PharmaCann, but the deal was terminated. The state currently has 129,316 patients registered in what is considered a fairly restrictive program.

There has also been little discussion of increasing the number of licenses other than to hint that new legislation would be addressing social equity issues. Only one of the state's providers is a female-led company, Etain and none are considered to fall under a person of color category.

The potential of legal New York adult-use cannabis sales have been estimated at $1.5 billion a year by 2023, although depending on the levels of taxation, a well-embedded illegal market may continue to thrive. In December of 2019, Michigan became the tenth state in the U.S. to legalize adult-use cannabis. Less than a year in, it's already outpaced Nevada to become the fifth highest-grossing state for cannabis sales and is on track to surpass $1 billion in sales, according to data from Headset. The entire state of Michigan has 7.3 million adults over the age of 21, New York City alone has over 8 million. So, those estimates are looking very low indeed.

Despite salivating over potential tax revenue, April is still a pretty aggressive timeline for New York to develop and administer a legal cannabis program. Even the most enthusiastic states have generally needed a year to develop and launch such a plan. If New York wants to accomplish that, it will need to lean on those already licensed companies and they will be the big winners in the New Jersey/New York race to legalization.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Debra Borchardt had no position in the securities mentioned.

TAGS: Economy | Investing | Markets | Stocks | Trading | Marijuana | Cannabis

More from Investing

Rule of the Week: Don't Fight the Fed

James "Rev Shark" DePorre
Jan 30, 2023 4:33 PM EST

We've got a mix of earnings, a rate decision and nervous investors.

3 High-Yield Dividend Tech Stocks for Income Investors

Bob Ciura
Jan 30, 2023 2:35 PM EST

Now could be a very good time to capitalize on sustainable income streams from a sector where dividend income is scarce.

Checking on AMD's Stock Charts Ahead of Tuesday's Earnings

Bruce Kamich
Jan 30, 2023 2:10 PM EST

Here's what to avoid for now.

Is This Mid-Cap Oil Stock Ready to Capture Its 'Big Winner' Potential?

Bruce Kamich
Jan 30, 2023 1:29 PM EST

Here's our technical strategy for trading oil producer Denbury.

Don't Fight the Fed? What About When the Fed Is Fighting Its Own Past?

Peter Tchir
Jan 30, 2023 1:00 PM EST

The biggest risk to markets in the coming weeks is the realization that the Fed has already gone far too far, and the economy is rolling over.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:27 PM EST REAL MONEY

    LIVE EVENT: Chris Versace and "Sarge" Guilfoyle Share Their Stock Market Insights

    This Monday, Jan. 30, at 12 p.m., our very own exp...
  • 11:48 AM EST REAL MONEY

    Watch Doug Kass on the Daily Rundown!

    In today's Action Alerts PLUS Daily Rundown, Doug ...
  • 11:03 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend On Real Money

    It's time to start using this power to build great...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login